Joanne Lynn, M.D., a geriatrician and health services researcher, will present the next Flexner Discovery Lecture on Sept. 22.

High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered.

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease.

Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF).